LLY

762.24

-0.35%↓

JNJ

177.06

+0.28%↑

ABBV

219.97

+1.65%↑

UNH

340.04

-0.16%↓

AZN

77.55

-0.35%↓

LLY

762.24

-0.35%↓

JNJ

177.06

+0.28%↑

ABBV

219.97

+1.65%↑

UNH

340.04

-0.16%↓

AZN

77.55

-0.35%↓

LLY

762.24

-0.35%↓

JNJ

177.06

+0.28%↑

ABBV

219.97

+1.65%↑

UNH

340.04

-0.16%↓

AZN

77.55

-0.35%↓

LLY

762.24

-0.35%↓

JNJ

177.06

+0.28%↑

ABBV

219.97

+1.65%↑

UNH

340.04

-0.16%↓

AZN

77.55

-0.35%↓

LLY

762.24

-0.35%↓

JNJ

177.06

+0.28%↑

ABBV

219.97

+1.65%↑

UNH

340.04

-0.16%↓

AZN

77.55

-0.35%↓

Strona główna・Stock List・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Open

SectorHealthcare

32.26 0.75

Buy Sell

Overview

Share price change

24h

Current

Min

31.98

Max

32.74

Key metrics
By Trading Economics
Income	-5.8M 40M
Sales	16M 200M
P/E Sector Avg	11.558 35.664
EPS	0.92
Profit margin	19.839
Employees	268
EBITDA	3M 59M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+56.03% upside

Dividends
By Dow Jones
Next Earnings	28 paź 2025

Market Stats
By TradingEconomics
Market Cap	21M 2.1B
Previous open	31.51
Previous close	32.26

News Sentiment

By Acuity

20%

80%

43 / 371 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

29.8 / N/A Support & Resistance

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

16 wrz 2025, 17:03 UTC

Major Market Movers

BrainsWay Shares Rise on FDA Clearance of Major Depressive Disorder Treatment

16 wrz 2025, 16:49 UTC

Major Market Movers

Acquisitions, Mergers, Takeovers

GD Culture Shares Drop After Deal for Pallas Capital

16 wrz 2025, 16:11 UTC

Major Market Movers

Corbus Shares Rise on FDA Fast-Track Designation for Cancer Drug

16 wrz 2025, 23:40 UTC

Market Talk

Nikkei May Decline as Yen Strengthens -- Market Talk

16 wrz 2025, 23:34 UTC

Market Talk

Gold Edges Higher Ahead of FOMC Decision -- Market Talk

16 wrz 2025, 23:20 UTC

Market Talk

Restaurant Brands NZ Can Outperform When Cycle Turns -- Market Talk

16 wrz 2025, 21:10 UTC

Acquisitions, Mergers, Takeovers

U.S. Investors, Trump Close In on TikTok Deal With China -- WSJ

16 wrz 2025, 20:51 UTC

Market Talk

U.S. Home Sales, New Home Listings Fall in August -- Market Talk

16 wrz 2025, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

16 wrz 2025, 20:50 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Basic Materials Roundup: Market Talk

16 wrz 2025, 20:25 UTC

Earnings

The AI Trade Has Stocks Near Highs Again. Some Tech Names Remain on the Sidelines -- Barrons.com

16 wrz 2025, 20:24 UTC

Earnings

These Stocks Moved the Most Today: Oracle, Tesla, Alphabet, Dave & Buster's, Chipotle, and More -- Barrons.com

16 wrz 2025, 19:19 UTC

Market Talk

U.S. Natural Gas Futures Extend Winning Streak -- Market Talk

16 wrz 2025, 18:52 UTC

Market Talk

Oil Futures Advance on Russia Concerns, Weak Dollar -- Market Talk

16 wrz 2025, 18:44 UTC

Market Talk

Global Equities Roundup: Market Talk

16 wrz 2025, 18:44 UTC

Market Talk

EssilorLuxottica Well-Positioned in Growing Smart-Glasses Market -- Market Talk

16 wrz 2025, 18:40 UTC

Acquisitions, Mergers, Takeovers

Details Emerge on U.S.-China TikTok Deal -- WSJ

16 wrz 2025, 18:38 UTC

Market Talk

Meta Seen With Long-Term Opportunity to Lead in Smart Glasses -- Market Talk

16 wrz 2025, 18:19 UTC

Market Talk

Gold Settles at New High Ahead of Fed Decision -- Market Talk

16 wrz 2025, 18:01 UTC

Market Talk

U.S. Dollar Weakness Supports Oil's Gains -- Market Talk

16 wrz 2025, 17:34 UTC

Market Talk

Any Question the Bank of Canada Will Cut Now Look to Have Vanished -- Market Talk

16 wrz 2025, 16:53 UTC

Earnings

Software Companies Are Fighting Back With AI. The Stocks Are Still Hurting. -- Barrons.com

16 wrz 2025, 16:20 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Basic Materials Roundup: Market Talk

16 wrz 2025, 16:15 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Global Commodities Roundup: Market Talk

16 wrz 2025, 16:09 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Global Energy Roundup: Market Talk

16 wrz 2025, 16:09 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Canada Industry Minister to Meet Mining CEOs on Merger -- Market Talk

16 wrz 2025, 15:35 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 wrz 2025, 15:35 UTC

Market Talk

Gold Soars Past $3,700 Ahead of Fed Decision -- Market Talk

16 wrz 2025, 15:22 UTC

Market Talk

More Investors Think Dollar is Overvalued in Latest BofA Survey -- Market Talk

16 wrz 2025, 15:21 UTC

Market Talk

Sterling Considered Most Overvalued in Nearly 10 Years -- Market Talk

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

56.03% upside

12 Months Forecast

Average 50.71 USD 56.03%

High 70 USD

Low 33 USD

Based on 8 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

Buy

Hold

Sell

Based on 8 analysts giving stock ratings to Harmony Biosciences Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

43 / 371 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.